Skip to content
Recall Observatory FDA recall evidence

Drug product

CIPROFLOXACIN TABLETS, USP, 500 mg, 100 Tablets (10 tablets per blister card. 10 blister cards per carton), Manufactured by: Mylan Pharmaceuticals Inc., Morgantown, WV --- NDC 51079-182-20.

D-0377-2015

September 26, 2013

Class II

Product summary

Firm
Mylan Institutional, Inc. (d.b.a. UDL Laboratories)
Event
Event 66607
Status
Terminated
Classification
Class II
Quantity
11,650 cartons
Official record key
drug-enforcement:D-0377-2015

Official wording

Reason: CGMP Deviations: Pharmaceuticals were produced and distributed with active ingredients not manufactured according to Good Manufacturing Practices

Code information: Lot Number: 3034630; Expiration Date: 12/13; NDC: 51079-182-20

Distribution pattern: Nationwide and Puerto Rico.

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations